<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04772508</url>
  </required_header>
  <id_info>
    <org_study_id>13/395</org_study_id>
    <nct_id>NCT04772508</nct_id>
  </id_info>
  <brief_title>Effect of Amnion Membrane With and Without Taurine on GCF TNF α Level.</brief_title>
  <official_title>Efficacy of Subgingivally Placed Amnion Membrane With and Without Taurine as an Adjunct to Scaling and Root Planing in the Treatment of Chronic Periodontitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maharishi Markendeswar University (Deemed to be University)</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Maharishi Markendeswar University (Deemed to be University)</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      45 sites in 15 patients with periodontal pockets ≥ 5mm were selected. These selected sites&#xD;
      were divided into 3 groups as Group A, B and C.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Group A (Control): 15 sites received only SRP, Group B: 15 sites received SRP with&#xD;
      subgingival placement of amnion membrane, Group C: 15 sites received SRP with subgingival&#xD;
      placement of Amnion membrane hydrated with Taurine.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 1, 2020</start_date>
  <completion_date type="Actual">March 13, 2021</completion_date>
  <primary_completion_date type="Actual">March 13, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Group A (Control): 15 sites received only SRP, Group B: 15 sites received SRP with subgingival placement of amnion membrane, Group C: 15 sites received SRP with subgingival placement of Amnion membrane hydrated with Taurine.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>patients and statistician are masked about treatment modality</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>TNF-α level</measure>
    <time_frame>changes from baseline to 45 days</time_frame>
    <description>TNF-α level in Gingival crevicular fluid</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Probing pocket depth (PPD)</measure>
    <time_frame>changes from baseline to 45 days</time_frame>
    <description>Probing pocket depth at selected site</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Relative attachment level (RAL)</measure>
    <time_frame>changes from baseline to 45 days</time_frame>
    <description>Relative attachment level from stent to base of the pocket</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Plaque index (PI)</measure>
    <time_frame>changes from baseline to 45 days</time_frame>
    <description>Plaque index (PI) - Silness and Loe 1964 site specific</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gingival index (GI)</measure>
    <time_frame>changes from baseline to 45 days</time_frame>
    <description>Gingival index (GI) - Loe and Silness 1963 site specific</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bleeding on probing (BOP)</measure>
    <time_frame>changes from baseline to 45 days</time_frame>
    <description>Bleeding on probing (BOP): Muhlemann HR &amp; Son 1971 sit specific</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">45</enrollment>
  <condition>Periodontitis</condition>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>15 sites received only scaling and root planing</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>15 sites received scaling and root planing with subgingival placement of amnion membrane</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group C</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>15 sites received scaling and root planing with subgingival placement of amnion membrane hydrated with Taurine</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Scaling and root planing</intervention_name>
    <description>15 sites with periodontal pockets ≥ 5mm received only SRP</description>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_label>Group C</arm_group_label>
    <other_name>SRP</other_name>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Amnion membrane</intervention_name>
    <description>15 sites with periodontal pockets ≥ 5mm received SRP along with placement of amnion membrane.</description>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_label>Group C</arm_group_label>
    <other_name>AM</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Taurine</intervention_name>
    <description>15 sites with periodontal pockets ≥ 5mm received SRP along with placement of amnion membrane hydrated with taurine.</description>
    <arm_group_label>Group C</arm_group_label>
    <other_name>T</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        •Systemically healthy patients with sites showing probing depth (PD) ≥ 5mm, clinical&#xD;
        attachment level (CAL) ≥ 4 mm, and vertical bone loss ≥ 3 mm on intraoral periapical&#xD;
        radiographs with no history of periodontal therapy or use of antibiotics in the preceding 6&#xD;
        months&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Any systemic disease that could influence the outcome of periodontal therapy.&#xD;
&#xD;
          -  Smokers, alcoholics &amp; patients with other adverse habits.&#xD;
&#xD;
          -  Pregnant or nursing women.&#xD;
&#xD;
          -  Any known allergy or hypersensitivity to any product used in the study.&#xD;
&#xD;
          -  Patients on long term systemic therapy (antibiotics, anti-inflammatory and any other).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>29 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>surinder sachdeva, M.D.S.</last_name>
    <role>Study Director</role>
    <affiliation>PROFESSOR</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Periodontology, M.M. College of Dental Sciences and Research.</name>
      <address>
        <city>Ambala</city>
        <state>Haryana</state>
        <zip>133207</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <reference>
    <citation>Giriş M, Depboylu B, Doğru-Abbasoğlu S, Erbil Y, Olgaç V, Aliş H, Aykaç-Toker G, Uysal M. Effect of taurine on oxidative stress and apoptosis-related protein expression in trinitrobenzene sulphonic acid-induced colitis. Clin Exp Immunol. 2008 Apr;152(1):102-10. doi: 10.1111/j.1365-2249.2008.03599.x. Epub 2008 Jan 28.</citation>
    <PMID>18241224</PMID>
  </reference>
  <reference>
    <citation>Gültekin SE, Sengüven B, Sofuoğlu A, Taner L, Koch M. Effect of the topical use of the antioxidant taurine on the two basement membrane proteins of regenerating oral gingival epithelium. J Periodontol. 2012 Jan;83(1):127-34. doi: 10.1902/jop.2011.100568. Epub 2011 May 16.</citation>
    <PMID>21574832</PMID>
  </reference>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>February 23, 2021</study_first_submitted>
  <study_first_submitted_qc>February 23, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 26, 2021</study_first_posted>
  <last_update_submitted>March 13, 2021</last_update_submitted>
  <last_update_submitted_qc>March 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Maharishi Markendeswar University (Deemed to be University)</investigator_affiliation>
    <investigator_full_name>DR SURINDER SACHDEVA</investigator_full_name>
    <investigator_title>PROFESSOR</investigator_title>
  </responsible_party>
  <keyword>periodontitis</keyword>
  <keyword>taurine</keyword>
  <keyword>amnion membrane</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

